White Paper

Perspectives On Trends In Outsourcing The Development And Manufacturing Of Biologics

Bioprocess Bioreactor Cleanroom GettyImages-532549174

Many factors must be considered when determining the best approach for development and manufacturing of a biopharmaceutical. The right strategy must align with organizational objectives, accelerate progress toward key milestones within regulatory expectations, and ensure quality and patient safety. Risk is always present and must be identified and weighed against the need to move quickly and remain compliant.

Outsourcing to an experienced CDMO can offer significant advantages in terms of speed, flexibility and risk mitigation. Use of an external partner can also reduce risk and provide flexibility when the timing of regulatory approval across multiple geographies is uncertain or delayed.

In this whitepaper, we share highlights from a global market research survey of small, mid-sized and large biopharmaceutical companies on trends related to outsourcing and share what attributes of an outsourcing partner that are sought by developers and manufacturers of biopharmaceuticals.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Outsourced Pharma? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: